Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Colleoni

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|April 12, 2003
Advances in the treatment of multiple myeloma: the role of thalidomideChristian Ribas, Gisele W B Colleoni
Clinical & Developmental Immunology|April 11, 2012
The role of regulatory T cells and TH17 cells in multiple myelomaWalter M T Braga, Djordje Atanackovic, Gisele W B Colleoni
Clinical & Developmental Immunology|April 7, 2012
Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapyFabricio de Carvalho, André L Vettore, Gisele W B Colleoni
Nutrition Reviews|March 4, 2025
Gut Microbiota and Metabolic Biomarkers Associated With LongevityBeatriz de Luca Silva, Maysa Seabra Cendoroglo, Gisele W B Colleoni
Immunotherapy|November 29, 2013
Understanding myeloma cancer stem cellsFábio Pascutti, Lucas Leite Cunha, Edgar Gil Rizzatti, et al.
Human Pathology|July 3, 2002
Expression of SSX genes in the neoplastic cells of Hodgkin's lymphomaGisele W B Colleoni, Paola Capodieci, Satish Tickoo, et al.
Human Pathology|May 13, 2004
Molecular analysis of gastric washings in the diagnosis and monitoring of gastric lymphomasBeiyun Chen, Gisele W b Colleoni, Paulo A Salazar, et al.
European Journal of Haematology|October 2, 2004
Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myelomaChristian Ribas, Gisele W B Colleoni, Maria Regina Regis Silva, et al.
Leukemia & Lymphoma|July 14, 2009
Proangiogenic cytokines produced by non-Hodgkin lymphoma tumor cells induce angiogenesis in infiltrated bone marrow samplesLeina Yukari Etto, Maria Regina Regis Silva, Maria Aparecida Dalboni, et al.
International Journal of Cancer|June 24, 2009
TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myelomaFabrício de Carvalho, Gisele W B Colleoni, Manuella S Sampaio Almeida, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|April 12, 2003
Advances in the treatment of multiple myeloma: the role of thalidomideChristian Ribas, Gisele W B Colleoni
Clinical & Developmental Immunology|April 11, 2012
The role of regulatory T cells and TH17 cells in multiple myelomaWalter M T Braga, Djordje Atanackovic, Gisele W B Colleoni
Clinical & Developmental Immunology|April 7, 2012
Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapyFabricio de Carvalho, André L Vettore, Gisele W B Colleoni
Nutrition Reviews|March 4, 2025
Gut Microbiota and Metabolic Biomarkers Associated With LongevityBeatriz de Luca Silva, Maysa Seabra Cendoroglo, Gisele W B Colleoni
Immunotherapy|November 29, 2013
Understanding myeloma cancer stem cellsFábio Pascutti, Lucas Leite Cunha, Edgar Gil Rizzatti, et al.
Human Pathology|July 3, 2002
Expression of SSX genes in the neoplastic cells of Hodgkin's lymphomaGisele W B Colleoni, Paola Capodieci, Satish Tickoo, et al.
Human Pathology|May 13, 2004
Molecular analysis of gastric washings in the diagnosis and monitoring of gastric lymphomasBeiyun Chen, Gisele W b Colleoni, Paulo A Salazar, et al.
European Journal of Haematology|October 2, 2004
Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myelomaChristian Ribas, Gisele W B Colleoni, Maria Regina Regis Silva, et al.
Leukemia & Lymphoma|July 14, 2009
Proangiogenic cytokines produced by non-Hodgkin lymphoma tumor cells induce angiogenesis in infiltrated bone marrow samplesLeina Yukari Etto, Maria Regina Regis Silva, Maria Aparecida Dalboni, et al.
International Journal of Cancer|June 24, 2009
TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myelomaFabrício de Carvalho, Gisele W B Colleoni, Manuella S Sampaio Almeida, et al.
Pageof 6